RTW — RTW Biotech Opportunities Share News
0.000.00%
Last trade - 00:00- $725.25m
- $931.80m
- $34.57m
Brief: Rtw Biotech Opportunities Ltd Reports Nav Of $1.70 Per Share As Of June 30
RTW Biotech Opp. - Monthly Valuation Update and Factsheet
RTW Biotech Opp. - Merck to acquire Verona Pharma
RTW Biotech Opp. - Holding(s) in Company
RTW Biotech Opp. - Update on Corxel Pharmaceuticals
RTW Biotech Opp. - Director/PDMR Shareholding
RTW Biotech Opp. - Update on Rocket Pharmaceuticals
RTW Biotech Opp. - Notice of AGM
RTW Biotech Opp. - Update on Artios Pharma
RTW Biotech Opp. - Jade Biosciences merges with Aerovate Therapeutics
RTW Biotech Opp. - Annual Financial Report
Brief: RTW Biotech Opportunities Reports Unaudited NAV As At 31 March 2025 At $1.69 Per Share
RTW Biotech Opp. - Director/PDMR Shareholding
RTW Biotech Opp. - Annual Financial Report
RTW Biotech Opp. - Notice of Annual Results
RTW Biotech Opp. - Material purchase by CIO of the Investment Manager
RTW Biotech Opp. - Director/PDMR Shareholding
Brief: RTW Biotech Opportunities Says Kailera Reports Positive Data In Ph2 Obesity Trial
Brief: RTW Biotech Opportunities Announces Series A Round Raises $200 Mln For Windward Bio